From Pharma Marketing Network Publishing

Order Beyond Results: Pharmaceutical & Healthcare Marketing in the AI Age, by R.J. Lewis. Intelligence is free. Permission isn’t. A decade after RESULTS, a candid look at what AI really changes for pharma and healthcare marketing, and what it doesn’t. When intelligence is abundant, trust, access, and time stay scarce.

THE NEW BOOK FROM R.J. LEWIS

Intelligence is free.
Permission isn’t.

Beyond Results book cover

Beyond ResultsPharmaceutical & Healthcare Marketing in the AI AgeBY R.J. LEWIS

A decade after RESULTS, a candid look at what AI really changes for pharma and healthcare marketing, and what it doesn’t. When intelligence is abundant, trust, access, and time stay scarce.

Order Now

LATEST ARTICLES

Young pediatric patient smiling while holding a teddy bear in a hospital room, illustrating hope, compassionate care, and the power of positive action.

Can Hope Be Operationalized? St. Jude Thinks So.

Can a brand make hope useful, rather than simply make people feel hopeful? St. Jude Children’s Research Hospital is exploring that question through research....
Siemens Healthineers transitions toward an independent Healthineers brand, highlighting the challenge of preserving trust and brand recognition.

Siemens Is Coming Off the Name. Can the Trust Stay?

A famous name can open doors. But can a healthcare company keep those doors open after removing that name? Siemens Healthineers plans to become...
Laptop displaying secure cloud data connections and healthcare analytics during a pharmaceutical marketing strategy meeting, illustrating media data neutrality.

Publicis Bought LiveRamp. Now Neutrality Is Part of the Product.

Publicis Groupe completed its acquisition of LiveRamp on November 2, 2026. Can shared marketing infrastructure remain neutral when one of the world's largest advertising...

R.J. Lewis’s New Book, Beyond Results: Pharmaceutical & Healthcare Marketing in the AI Age,...

A decade after RESULTS, R.J. Lewis examines what AI really changes for pharma and healthcare marketing, and what it doesn't November 17, 2026: Beyond Results:...
Yutrepia patent settlement represented by a legal gavel, medication bottle, and laptop displaying HCP targeting, CRM workflows, and pharmaceutical marketing compliance controls.

A Patent Settlement Just Rewrote Liquidia’s Target List.

One patent settlement can make a pharmaceutical sales team's target list obsolete almost overnight. That is the overlooked story behind Liquidia's October 2026 agreement...
Healthcare provider discussing oral and injectable PrEP options with a patient to support informed HIV prevention decisions.

PrEP Marketing Has a New Job: Help Patients Choose, Not Just Know.

Knowing that HIV prevention exists is not the same as knowing which option fits someone's life. That's why helping patients understand their PrEP options...
Medicare drug pricing policy displayed alongside pharmaceutical vials, syringes, and medication packaging, illustrating changes to pharma formulation strategy.

CMS Just Made the “New Formulation” Playbook Less Valuable.

A new delivery method can give an established drug a fresh commercial story. Now, CMS is changing the rules. CMS's latest Medicare decision could...
Woman examining an autumn maple leaf with irregular edges and dark spots, symbolizing melanoma's ABCDE warning signs in BMS's fall awareness campaign.

Summer Was Over. BMS Launched the Melanoma Campaign Anyway.

Autumn leaves usually signal the end of summer. For Bristol Myers Squibb Canada, they became a reason to revisit skin health. Its November 2026...
Prescription drug bottles beside a declining TV advertising spending chart, with a baseball game on television and a streaming platform on a laptop.

Pharma TV Spending Dropped 14.5%. Baseball May Be Part of the Reason.

A 14.5% drop in prescription drug TV spending sounds like an industry retreat. But what if part of the decline came from a shorter...
Healthcare researcher reviewing telehealth patient data, treatment timelines, and clinical research analytics on a digital dashboard.

Ro Treats Patients. Now It Wants Their Care Journeys to Become Research.

A patient starts a GLP-1 medication online, reports side effects, and returns for follow-up care. Each interaction creates information about what treatment looks like...
- Advertisement -